Metrics of effectiveness within Alzheimer disease research and across diseases
Berg, L.; Montgomery, R.
Alzheimer Disease and Associated Disorders 11(Suppl 6): 181-183
1997
ISSN/ISBN: 0893-0341 PMID: 9437465 Document Number: 482269
Document emailed within 1 workday
Related Documents
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Hattori, H. 2013: Effectiveness and limitation of newly approved drugs for Alzheimer's disease Seishin Shinkeigaku Zasshi 115(1): 22-31
Weiner, M.F. 1991: Advances in clinical research in Alzheimer's disease Comprehensive Therapy 17(8): 9-13
Shvaloff, A.; Neuman, E.; Guez, D. 1996: Lines of therapeutics research in Alzheimer's disease Psychopharmacology Bulletin 32(3): 343-352
Bullock, R.; Passmore, P.; Wilkinson, D.; Howard, R.; Jones, R. 2000: Effectiveness of rivastigmine in Alzheimer's disease. Participation in trials should be based on clinical uncertainty, not enforcement Bmj 320(7233): 511-512
Warshaw, G. 1997: Assessing physical status in Alzheimer disease research Alzheimer Disease and Associated Disorders 11(Suppl): 66-72
Nordstedt, C.; Näslund, J.; Tjernberg, L.O.; Terenius, L. 1995: A breakthrough for research on Alzheimer disease. a model for drug testing Lakartidningen 92(18): 1899-1900
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
MacQueen, K.M.; Bhan, A.; Frohlich, J.; Holzer, J.; Sugarman, J. 2015: Evaluating community engagement in global health research: the need for metrics Bmc Medical Ethics 16: 44
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Galeazzi, F.; Tanlongo, F.; Ardizzone, V. 2012: DECIDE: a user friendly web-based service for early diagnosis and research on Alzheimer's disease Studies in Health Technology and Informatics 175: 108
Bufill, E.; Blesa, R. 2006: Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy? Revista de Neurologia 42(1): 25-33
Bendix, J. 2009: Clinical Centers of Excellence: Dementia. UCLA Mary S. Easton Center for Alzheimer's Disease Research. Los Angeles, California Medical Economics 86(23): 36
Burbaeva, G.S.; Savushkina, O.K.; Dmitriev, A.D. 1999: Brain isoforms of creatine kinase in health and mental diseases: Alzheimer's disease and schizophrenia Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1: 20-24
Antuono, P.G. 1995: Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group Archives of Internal Medicine 155(16): 1766-1772
Domper, M.; Richter, J.A.; Lacruz, F.; Arbizu, J.; Manubens, J.M.; García, M.J.; Martínez-Lage, M. 1991: Brain photon emission tomography. Value of the corticocerebellar index and gammagraphic patterns in Alzheimer's disease and other diseases Medicina Clinica 96(1): 1-5